KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Manhattan Associates (MANH) EBT (2016 - 2025)

Historic EBT for Manhattan Associates (MANH) over the last 17 years, with Q3 2025 value amounting to $78.4 million.

  • Manhattan Associates' EBT rose 265.7% to $78.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $280.1 million, marking a year-over-year increase of 616.46%. This contributed to the annual value of $266.8 million for FY2024, which is 2487.14% up from last year.
  • Latest data reveals that Manhattan Associates reported EBT of $78.4 million as of Q3 2025, which was up 265.7% from $74.5 million recorded in Q2 2025.
  • Manhattan Associates' 5-year EBT high stood at $78.4 million for Q3 2025, and its period low was $25.1 million during Q1 2021.
  • Its 5-year average for EBT is $52.1 million, with a median of $51.5 million in 2023.
  • Within the past 5 years, the most significant YoY rise in Manhattan Associates' EBT was 6919.85% (2022), while the steepest drop was 940.38% (2022).
  • Manhattan Associates' EBT (Quarter) stood at $26.9 million in 2021, then soared by 69.2% to $45.5 million in 2022, then surged by 31.18% to $59.7 million in 2023, then grew by 4.94% to $62.7 million in 2024, then rose by 25.12% to $78.4 million in 2025.
  • Its last three reported values are $78.4 million in Q3 2025, $74.5 million for Q2 2025, and $64.5 million during Q1 2025.